Renal function recovery after radical nephroureterectomy for upper tract urothelial carcinoma

被引:10
作者
Lee, Byron H. [1 ]
Zabor, Emily C. [2 ]
Tennenbaum, Daniel [1 ]
Furberg, Helena [2 ]
Benfante, Nicole [1 ]
Coleman, Jonathan A. [1 ]
Jaimes, Edgar A. [3 ]
Russo, Paul [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, 1275 York Ave, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 1275 York Ave, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Renal Serv, 1275 York Ave, New York, NY 10065 USA
关键词
Upper tract urothelial carcinoma; Renal function recovery; Radical nephroureterectomy; Hydronephrosis; NEOADJUVANT CHEMOTHERAPY; PREOPERATIVE HYDRONEPHROSIS; SURVIVAL; GUIDELINES; MANAGEMENT; ADJUVANT; DECLINE;
D O I
10.1007/s00345-017-2139-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To understand the longitudinal renal function trends in patients undergoing radical nephroureterectomy (RNU) and identify clinicopathologic characteristics associated with estimated glomerular filtration rate (eGFR) recovery. 147 patients were available for analysis. Longitudinal eGFR trends were assessed by plotting each patient's eGFR measurements over time. The patient population was dichotomized using eGFR < 60 ml/min/1.73 m(2) versus >= 60 ml/min/1.73 m(2). Cumulative incidence and competing risk regression analysis were used to estimate recovery of postoperative eGFR to the preoperative level and identify clinicopathologic characteristics associated with eGFR recovery. Median age was 68.7 years and median preoperative eGFR was 55.9 ml/min/1.73 m(2). 63.6% were male and 95.8% were white. The cumulative incidence of eGFR recovery was significantly higher in patients with baseline eGFR < 60 ml/min/1.73 m(2) compared to those with baseline eGFR >= 60 ml/min/1.73 m(2) (p = 0.01), with recovery rates at 2 years of 56.6% vs. 27.7%, respectively. Multivariable analysis revealed that preoperative hydronephrosis (HR 1.80) and preoperative eGFR < 60 ml/min/1.73 m(2) (HR 1.87) were associated with increased chance of eGFR recovery. Over half of patients with preoperative eGFR < 60 ml/min/1.73 m(2) achieved eGFR recovery within the first 3 years after RNU, and hydronephrosis was a significant predictor of recovery. These findings should be considered when counseling patients regarding chronic kidney disease progression after RNU and timing of perioperative chemotherapy for high risk tumors.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 25 条
[1]  
[Anonymous], NETWORK NCC BLADDER
[2]   Perioperative chemotherapy in upper tract urothelial carcinoma: a comprehensive review [J].
Aziz, Atiqullah ;
Dobruch, Jakub ;
Hendricksen, Kees ;
Kluth, Luis A. ;
Necchi, Andrea ;
Noon, Aidan ;
Rink, Michael ;
Roghmann, Florian ;
Seiler, Roland ;
Gontero, Paolo ;
Kassouf, Wassim ;
Shariat, Shahrokh F. ;
Xylinas, Evanguelos .
WORLD JOURNAL OF UROLOGY, 2017, 35 (09) :1401-1407
[3]   Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma [J].
Hashimoto, Takeshi ;
Ohno, Yoshio ;
Nakashima, Jun ;
Gondo, Tatsuo ;
Nakagami, Yoshihiro ;
Namiki, Kazunori ;
Horiguchi, Yutaka ;
Yoshioka, Kunihiko ;
Ohori, Makoto ;
Tachibana, Masaaki .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (11) :1064-1068
[4]   Preoperative Hydronephrosis: Independent Predictor for Changes in Renal Function Following Nephroureterectomy [J].
Hoshino, Katsura ;
Kikuchi, Eiji ;
Tanaka, Nobuyuki ;
Akita, Hirotaka ;
Ito, Yujiro ;
Miyajima, Akira ;
Jinzaki, Masahiro ;
Oya, Mototsugu .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (03) :202-207
[5]   KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD [J].
Inker, Lesley A. ;
Astor, Brad C. ;
Fox, Chester H. ;
Isakova, Tamara ;
Lash, James P. ;
Peralta, Carmen A. ;
Tamura, Manjula Kurella ;
Feldman, Harold I. ;
Rocco, Michael V. ;
Berns, Jeffrey S. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) :713-735
[6]   Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma [J].
Kaag, Matthew ;
Trost, Landon ;
Thompson, R. Houston ;
Favaretto, Ricardo ;
Elliott, Vanessa ;
Shariat, Shahrokh F. ;
Maschino, Alexandra ;
Vertosick, Emily ;
Raman, Jay D. ;
Dalbagni, Guido .
BJU INTERNATIONAL, 2014, 114 (05) :674-679
[7]   Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative Chemotherapy [J].
Kaag, Matthew G. ;
O'Malley, Rebecca L. ;
O'Malley, Padraic ;
Godoy, Guilherme ;
Chen, Mang ;
Smaldone, Marc C. ;
Hrebinko, Ronald L. ;
Raman, Jay D. ;
Bochner, Bernard ;
Dalbagni, Guido ;
Stifelman, Michael D. ;
Taneja, Samir S. ;
Huang, William C. .
EUROPEAN UROLOGY, 2010, 58 (04) :581-587
[8]   Population-Based Case-Control Study of Chinese Herbal Products Containing Aristolochic Acid and Urinary Tract Cancer Risk [J].
Lai, Ming-Nan ;
Wang, Shuo-Meng ;
Chen, Pau-Chung ;
Chen, Ya-Yin ;
Wang, Jung-Der .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (03) :179-186
[9]   Chronic Kidney Disease After Nephroureterectomy for Upper Tract Urothelial Carcinoma and Implications for the Administration of Perioperative Chemotherapy [J].
Lane, Brian R. ;
Smith, Armine K. ;
Larson, Benjamin T. ;
Gong, Michael C. ;
Campbell, Steven C. ;
Raghavan, Derek ;
Dreicer, Robert ;
Hansel, Donna E. ;
Stephenson, Andrew J. .
CANCER, 2010, 116 (12) :2967-2973
[10]   A Systematic Review and Meta-analysis of Adjuvant and Neoadjuvant Chemotherapy for Upper Tract Urothelial Carcinoma [J].
Leow, Jeffrey J. ;
Martin-Doyle, William ;
Fay, Andre P. ;
Choueiri, Toni K. ;
Chang, Steven L. ;
Bellmunt, Joaquim .
EUROPEAN UROLOGY, 2014, 66 (03) :529-541